Oral Cancer Screening and Education in Hong Kong

Sponsor
The University of Hong Kong (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04487938
Collaborator
(none)
3,190
36

Study Details

Study Description

Brief Summary

This study will be conducted to obtain data on oral cancer risk factors to generate machine learning models with good predictive accuracy for stratifying individuals with high-oral cancer risk and delineating high-risk and low-risk oral lesions. Likewise, this study will seek to provide oral cancer-related health education and training on oral-self-examination for beneficiaries

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention utilised

Study Design

Study Type:
Observational
Anticipated Enrollment :
3190 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
THE HONG KONG ORAL CANCER EDUCATION AND SCREENING (HOCES) PROGRAM: REFINING DISEASE PREVENTION, RISK STRATIFICATION AND EARLY DETECTION
Anticipated Study Start Date :
Aug 1, 2021
Anticipated Primary Completion Date :
Jul 31, 2023
Anticipated Study Completion Date :
Jul 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Tobacco use and/or alcohol consumption

Other: No intervention utilised
No intervention utilised

No tobacco use and/or alcohol consumption

Other: No intervention utilised
No intervention utilised

Outcome Measures

Primary Outcome Measures

  1. Accuracy of machine learning algorithms for predicting high-risk persons [24 months]

    Predictive accuracy of the ML classifiers for forecasting individuals with or likely to develop high-risk lesions within 24 months of first screening encounter based on demographic and lifestyle information.

  2. Accuracy of machine learning algorithms for discriminating high-risk and low-risk lesions [24 months]

    Predictive accuracy of ML classifiers for classifying high-risk and low-risk lesions based on demographic and lifestyle risk factors, oral high-risk HPV status, and salivary DNA hypermethylation levels.

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy individuals satisfying age and residential area criteria with no previous history of oral cancer. Individuals with a history of other cancers will be included in the study provided they have been in remission for more than three years.
Exclusion Criteria:
  • Participants with reduced mouth opening (irrespective of the cause) to permit proper administration of VOE or photosensitive epilepsy will be excluded. Likewise, those who decline the provision of written consent or participation in any part of the study.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • The University of Hong Kong

Investigators

  • Principal Investigator: Peter Thomson, The University of Hong Kong

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Professor Peter James Thomson, Professor, The University of Hong Kong
ClinicalTrials.gov Identifier:
NCT04487938
Other Study ID Numbers:
  • thomsonp@hku.hk
First Posted:
Jul 27, 2020
Last Update Posted:
Jul 27, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2020